Form 4 for TELA TELA Bio, Inc.
Accepted 2022-06-23 00:00:00 ET · period of report 2022-06-02 · accession 0001104659-22-073703 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2022-06-23 | 2022-06-02 | TELA | Quaker BioVentures Capital II, L.P. | 10% | J - Other | $0.00 | -1.75M | 0 | -100% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2022-06-02 | J | D | 1,751,100 | $0.00 | 0 | D | — | — | (F2) Quaker BioVentures Capital II, L.P., the general partner of Quaker BioVentures II, L.P., received its pro rata shares in the distribution and in turn distributed all such shares to its own partners. |